疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

: ~- e: U( g+ V9 a

Vaccines, 6th Edition

7 s1 U4 [3 s- I; _2 Y4 K$ t* I& _' JApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

! O$ I( L  m0 L% whttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
* n1 s* c; R  Z% y. b1 i1 A short history of vaccination 1
; |$ n2 t3 Z4 }% k, R2 Vaccine immunology 14
3 u- H9 p7 S; b1 F. H3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
, J0 J) d7 ?! I6 Vaccine additives and manufacturing residuals in the United States:
4 C( o& i  a8 olicensed vaccines 71
7 _1 b4 O' z# R7 Passive immunization 80
8 General immunization practices 88
2 h8 j, a% x1 M- |8 ]. K  nSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
" o+ A) o. K8 ]12 Diphtheria toxoid 153
& S4 U" m( I2 h" l- r& r) Z13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
' J3 [/ }9 ?/ o) D& w15 Hepatitis B vaccines 205
- g6 u! l. y( K" a+ g$ p16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
& P4 w. w9 }; [- Y% H18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
, f& v3 ?( `, D- ?  F1 V' l  `21 Meningococcal vaccines 388
7 I" v- z% g3 [! X' Z22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
9 B$ k/ H0 [7 {+ m) v* O28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
0 x# O: q# r9 I2 b: `+ o30 Rotavirus vaccines . 669
1 _4 X" v( w9 _31 Rubella vaccine 688
' ]% p% N. c- A4 d# w8 b: I32 Smallpox and vaccinia 718
6 l2 O) W( {6 n2 Z5 O% s33 Tetanus toxoid 746
4 T! c0 ~/ u- n7 T; i2 K5 e1 B34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
9 L" I; @# _2 c0 r36 Typhoid fever vaccines 812
37 Varicella vaccine 837
/ e0 L) _% @! d1 A3 m38 Yellow fever vaccine 870
; y# j0 R! b+ m5 }, c. f39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
/ g* C/ D3 R3 m42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
" H$ n. V; c+ ^! S! z47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
7 ~$ Q+ G" ^; j0 ]5 m50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
7 J- A) W( ?: A( D  O5 b52 Lyme disease vaccines 1122
& @8 Q4 f# t, {# c0 r53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
& T% L9 v. I/ \56 Parasitic disease vaccines 1154
9 Y$ B$ x$ D  L) a# @, M+ f4 J57 Staphylococcus aureus vaccines 1161
" q# _/ t- B* P, X58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
1 P& ?3 c) R! F) u" y60 Technologies for making new vaccines 1182
1 ?. J8 [/ O$ F61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
5 K* p$ J, H* {6 ~* n" C2 r8 h6 ISECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
8 ^% x: N9 m, X2 T64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
5 a  ~1 G- L. Q67 Immunization in the United States 1310
& f! `' K+ o; |. I5 s68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
0 ~8 s9 [9 ^! d& W71 Community immunity 1395
- V* ?& d2 f, a% W3 Q6 j72 Economic analyses of vaccine policies 1413
3 I: ?9 q. A; {) p- d" X73 Regulation and testing of vaccines 1427
6 B) F9 O9 }# f& I74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
- i& s5 \, |( U78 Ethics 1508

+ S1 P/ L$ c/ I) g

, v2 O% t6 q3 Q) k/ i6 H

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

* Y! F5 S' G! I$ XVaccines, 6th Edition
$ [" }: ^. v8 o8 T% n3 x0 V
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

! k$ L2 M! ?" m' vhttp://yun.baidu.com/share/link? ... 1&uk=3810996606

0 Y2 O1 I! E; h7 ?8 {SECTION 1: General aspects of vaccination
  B2 M# v4 n) N1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
9 I3 L' Z: x4 _4 D/ P4 Vaccine manufacturing 44
+ c: L7 x) e; ~; n4 T7 E  o5 Evolution of adjuvants across the centuries 58
/ g$ C- K- h7 H' `2 \  y6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
5 H9 ~7 k" F" S! A7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
- j8 X( l1 m8 U8 `& N9 Adenovirus vaccines 113
10 Anthrax vaccines 127
2 z8 J! V- A1 V% a11 Cholera vaccines 141
; T2 f  j0 l9 M5 B( h+ O12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
( ^# {( ]- ~6 v" E( ^15 Hepatitis B vaccines 205
7 {% i5 Q* y' T3 n% B; q' L! G16 Human papillomavirus vaccines 235
7 Q5 ]3 M9 _/ j: r& X17 Inactivated influenza vaccines 257
: ?+ n, B& X8 ?18 Influenza vaccine-live 294
) C: n+ i* `3 x0 g! j9 z7 ~7 F; z$ V19 Japanese encephalitis vaccines 312
. N3 O9 ^4 H  M; W$ K$ l20 Measles vaccines 352
2 C! _2 o0 k% ]  X21 Meningococcal vaccines 388
7 l! ]9 L+ x. O3 o: ?) z$ [22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
& j9 g5 X) _5 P  o2 S25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
9 U, |3 v# D3 x8 R; x- ~3 D5 o28 Poliovirus vaccine-live 598
9 |' f4 L$ C% M8 O* ]! |29 Rabies vaccines .646
0 M  Q: x, s5 v- ], P  _) C, p30 Rotavirus vaccines . 669
5 }( g" p1 L3 ?$ \: d31 Rubella vaccine 688
4 I. D0 b) `6 B9 _7 w, e6 E$ \2 r32 Smallpox and vaccinia 718
0 }. P( `2 P) F* P( w. \7 y33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
" N+ }) E$ [- Q4 ~) W" C  ?- d35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
; N% ]4 i% I& v+ i39 Zoster vaccine 969
7 g. I. l' a1 Z$ `$ ]; e40 Combination vaccines 981
! l. U5 @- J, p6 E4 BSECTION 3: Vaccines in development and new vaccine strategies
& [" \8 v9 D# E41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
% y0 h) Y8 v) i% U3 O3 Y& o; b0 s45 Diarrhea caused by bacteria 1052
+ |# f6 D6 _  L: D3 m46 Ebola vaccine 1060
7 N( ~/ l. X8 t, }' _$ u47 Epstein-Barr virus vaccines 1068
) g  t2 r) Q, H* m" W# Q% O0 B48 Hepatitis C vaccines 1074
5 `! j2 G6 t5 I; R/ r49 Hepatitis E vaccines 1085
; v- f4 t; N3 c. A+ l! {& a50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
# V, \' n, F; ~' ^3 H: ~* U- x52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
* u4 H  m! \9 c$ V& {56 Parasitic disease vaccines 1154
$ f" \5 Y8 H+ E% O9 m6 n57 Staphylococcus aureus vaccines 1161
( `8 n) Z1 r6 ^* x4 N$ m58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
+ n9 N: E! `- N- f$ ]8 x8 `SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
( m' t& `  h% j2 ^9 @! p6 O% `: A64 Vaccination of human immunodeficiency virus-infected persons 1257
2 d0 Z, N# e/ z) m  S- o/ ^65 Vaccines for international travel 1270
3 s' W- P% R- Z" X. k66 Vaccines for health care personnel 1290
$ W2 j# K6 t7 ?SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
5 ]$ C7 v! j' O% J5 _; ]68 Immunization in Europe . 1334
% E# y& H" k% w0 n69 Immunization in the Asia-Pacific region 1353
6 P. x9 {9 W# f: U2 r. [2 M# n70 Immunization in developing countries 1369
2 \- y( u% ^3 v9 {7 @2 r71 Community immunity 1395
. N! `9 V* g# E! k& x2 k' g1 Q72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
7 v2 ]( ^  N; B, P76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508
: ?' T4 h5 q& M  l$ y1 j

) i- j6 I- k, v( j: y

casarett

Vaccines, 6e, 2012
8 h* t8 V* l# w2 K: R. K) o
Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
8 S: p- w$ a8 e' r9 E2 jLanguage: English
ISBN-10: 1455700908
! ?( H3 x$ b# W1 TSize: 52.3mb (original pdf)
# b' P. n- ]- M! z8 |" y6 C
2013 BMA Medical Book Awards Highly Commended in Public Health!
% @- D9 |8 y! N+ k0 QApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
7 ?5 `! m7 R- _+ c
  |5 `' W8 Y1 e" V( `Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
, G7 M4 D- X, |: `- [+ YStay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
* K3 B  w; z5 e- b# z
Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96